Status:
COMPLETED
Prevention of Ectopic Bone Related Pain and Disability After Hip Replacement Surgery With Peri-Operative Ibuprofen
Lead Sponsor:
The George Institute
Collaborating Sponsors:
National Health and Medical Research Council, Australia
Medical Benefits Fund Australia Pty Ltd
Conditions:
Osteoarthritis, Hip
Arthroplasty, Replacement, Hip
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
The primary aim of this randomised trial is to determine the effects of a short peri-operative course of treatment with a non-steroidal anti-inflammatory drug (NSAID), ibuprofen, on the long-term cons...
Detailed Description
Methodology: The study is a multicentre, randomised, double blind, placebo-controlled trial. 1000 patients undergoing elective total hip replacement surgery from 20 orthopaedic centres in Australia a...
Eligibility Criteria
Inclusion
- Patient undergoing elective total hip replacement surgery, or revision thereof -
Exclusion
- A definite indication or contra-indication for treatment with a NSAID during the 14-day study treatment period, in the opinion of the treating clinician.
- \-
Key Trial Info
Start Date :
February 1 2002
Trial Type :
INTERVENTIONAL
End Date :
May 1 2004
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00145730
Start Date
February 1 2002
End Date
May 1 2004
Last Update
November 29 2006
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.